AKT1 and metabolic disease: Anthocyanins, as natural bioactive compounds, hold significant promise in managing obesity and related metabolic disorders through their modulation of the PI3K/Akt signaling pathway and its downstream targets, such as GLUT4, FOXO, GSK3β, and mTOR.